FindTrial
Sign In

Observational study on suspected COVID 19 patients admitted to ICU

Epidemiological study of patients admitted in intensive care unit with severe acute respiratory illness with possible diagnosis of COVID19 (EPIC19) - EPIC 19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025858
Enrollment
500
Registered
2020-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J189- Pneumonia, unspecified organism

Interventions

None listed

Sponsors

Dr Amarja Ashok Havaldar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with severe acute respiratory illness and with possible diagnosis of COVID, requiring intensive care will be included

Exclusion criteria

Exclusion criteria: Patients with respiratory failure or pneumonia not explained by COVID will be excluded.

Design outcomes

Primary

MeasureTime frame
To study the epidemiology and clinical characteristics of patients admitted with SARI possibly due to COVID19 and their outcome Timepoint: ICU mortality at 4 weeks—

Secondary

MeasureTime frame
Number of ventilator free days ICU length of stay ICU mortality Study correlation between steroid and mortality Correlation between different biomarkers and mortality Timepoint: Hospital mortality at 90 days—

Countries

India

Contacts

Public ContactDr Amarja Ashok Havaldar

St Johns Medical college

amarjahavaldar@rediffmail.com9036082112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 8, 2026